Chart-Typ:
Zeitraum:
| XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 03.07.2026 | Folgende Wertpapiere werden in den Handel an folgenden Handelsplätzen (MIC Code) im Quotation Board an der Frankfurter Wertpapierbörse (FWB) aufgenommen. Die Notierung an anderen Handelsplätzen im Quotation... ► Artikel lesen |
| Tilray Brands, Inc.: Tilray Brands Strengthens Global Medical Cannabis Platform and Canadian Patient Access Through HelloMD Acquisition | NEW YORK and TORONTO, June 29, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY) ("Tilray"), a global leader in medical cannabis, today announced the acquisition of HelloMD Corporation... ► Artikel lesen |
| Tilray Brands, Inc.: BrewDog and Tilray Beer Add Canada to The World's Biggest Bar Tab as Canada Advances to the Next Round | Canada, England or the U.S. to the final? BrewDog and Tilray Beer are ready to pour a £1 million bar tab for fans across participating BrewDog pubs1 and Tilray-owned brewpubs2.
NEW YORK and... ► Artikel lesen |
| Volatus Aerospace Inc.: Volatus Aerospace to Showcase Multi-Domain Capabilities at MASS 2026 | TORONTO, July 09, 2026 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. ("Volatus" or the "Company") (TSX: FLT) (OTCQX: TAKOF) (Frankfurt: ABB), a Canadian-headquartered global aerospace and defence company... ► Artikel lesen |
| Volatus Aerospace, TKMS und Rheinmetall: Drei Aktien für den nächsten Rüstungsboom | Der Rüstungsboom läuft längst noch nicht aus, sondern entfacht immer wieder neu, denn der militärische Nachholbedarf rund um den Globus bleibt angesichts vieler Krisenherde enorm. Für Anleger eröffnen... ► Artikel lesen |
| Volatus Aerospace Inc.: Volatus Aerospace Advances Canada's Next Chapter in Autonomous Aviation | TORONTO, July 08, 2026 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. ("Volatus" or the "Company") (TSX: FLT) (OTCQX: TAKOF) (Frankfurt: ABB), a Canadian-headquartered global aerospace and defence company... ► Artikel lesen |
| Editas Medicine, Inc.: Editas Medicine Reports New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at the American Society of Gene and Cell Therapy 2026 Annual Meeting | CAMBRIDGE, Mass., May 14, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company developing transformative medicines for serious diseases, shared new preclinical... ► Artikel lesen |
| Editas Medicine, Inc.: Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of the Broad Institute in CRISPR/Cas9 Interference | CAMBRIDGE, Mass., March 27, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today... ► Artikel lesen |
| Editas Medicine, Inc.: Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates | Lead candidate, EDIT-401, which demonstrated >90% mean LDL-C reduction in preclinical studies, remains on track for IND/CTA submission by mid-2026 Preparing to initiate Company's first-in-human clinical... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BOLT PROJECTS HOLDINGS INC finden Sie auf Wallstreet Online.